Statistics
Publications
6
Citations
3.4K
H-Index
6
Active since
2003
Thomas Salko is an author at Novartis (Switzerland) specializing in pharmacology, cardiovascular pharmacotherapy, and pharmacotherapy.
Publications per year
2003–2017
6
6
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Richard G. Langley, Boni E. Elewski, Mark Lebwohl et al. · New England Journal of Medicine · 2014 · 2K citations · Full text
Medicine, Dermatology, Immunology +14
Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +13
Michel Farnier, Thomas Salko, Jonathan L. Isaacsohn et al. · The American Journal of Cardiology · 2003 · 41 citations
Michel Farnier, Michele Bortolini, Thomas Salko et al. · The American Journal of Cardiology · 2003 · 20 citations
1–5 of 6